Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / pyxis oncology promising research amid cash constrai

PYXS - Pyxis Oncology: Promising Research Amid Cash Constraints

Pyxis Oncology Inc.

2024-06-10 05:54:47 ET

Summary

  • Pyxis Oncology develops innovative therapeutics for hard-to-treat cancers using antibody-drug conjugates and immunotherapies.
  • The company's pipeline includes PYX-201 and PYX-106, targeting multiple solid tumor types, with preliminary data expected in 2024.
  • Pyxis recently announced a workforce reduction and sold the royalties and commercialization rights of Beovu to extend its cash runway.
  • Despite innovative technology, PYXS faces financial constraints and early-stage development risks.
  • A neutral stance on PYXS is prudent due to speculative IP and potential shareholder dilution.

...

For further details see:

Pyxis Oncology: Promising Research Amid Cash Constraints
Stock Information
Company Name: Pyxis Oncology Inc.
Stock Symbol: PYXS
Market: NASDAQ
Website: pyxisoncology.com
Menu
PYXS PYXS Quote PYXS Short PYXS News PYXS Articles PYXS Message Board
Get PYXS Alerts

News, Short Squeeze, Breakout and More Instantly...